Micro-injection-mediated hematopoietic stem cell gene therapy

Current Opinion in Molecular Therapeutics

Volumn 2, Issue 4, 2000, Pages 412-419

  Davis, B R ^a   Brown, D B ^a   Prokopishyn, N L ^a   Yannariello Brown, J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Gene repair; Hematopoietic stem cells; Micro injection; Synthetic microchromosomes

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; DNA; OLIGONUCLEOTIDE; RNA; VIRUS VECTOR;

ARTICLE; GENE; GENE DELETION; GENE MUTATION; GENE TARGETING; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; LONG TERMINAL REPEAT; MICROINJECTION; MINICHROMOSOME; NONHUMAN; TRANSGENE;

ANIMALS; DNA; GENE THERAPY; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICROINJECTIONS; RNA; TRANSDUCTION, GENETIC; VIRUSES;

ADENO-ASSOCIATED VIRUS; LENTIVIRUS; PRIMATES; UNIDENTIFIED RETROVIRUS;

EID: 0033844703     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Gene therapy of human severe combined immonudeficiency (SCID)-X1 disease
2. Gene therapy for the hemoglobin disorders: Past, present, and future
3. Targeted gene modification for gene therapy of stem cells
4. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity
5. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell
6. KDR receptor: A key marker defining hematopoietic stem cells
7. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species
8. A newly discovered class of human hematopoietic cells with SCID- repopulating activity
9. CD34: To select or not to select? That is the question
10. 1 human hematopoietic stem cells
11. Identification of primitive human hematopoietic cells capable of repopulating NOD/SClD mouse bone marrow: Implications for gene therapy
12. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
13. A functional comparison of CD34+CD38- cells in cord blood and bone marrow
14. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells
15. High efficiency retroviral-mediated gene transduction into CD34+ cells purified from peripheral blood of breast cancer patients primed with chemotherapy and granulocyte-macrophage colony-stimulating factor
16. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo
17. Full activity from human β-globin locus control region transgenes requires 5' HS1, distal β-globin promoter, and 3' β-globin sequences
18. Regulated high-level human β-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer
19. Generation of a high-titer retroviral vector capable of expressing high levels of the human β-globin gene
20. Mutagenesis of retroviral vectors transducing human β-globin gene and β-globin locus control region derivatives results in stable transmission of an active transcriptional structure
21. Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human β-globin in engrafted mice
22. Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells
23. Stable expression of selectable genes introduced into human hematopoietic stem cells by electric field-mediated DNA transfer
24. New apparatus and methods for the dissection and injection of living cells
25. A microsurgical methodology for human cells in vitro: Evolution and applications
26. Microsurgical cell nucleus transplantation in mammalian cells
27. Transformation of NIH 3T3 cells by micro-injection of Ha-ras p21 protein
28. High efficiency transformation by direct micro-injection of DNA into cultured mammalian cells
29. Transient complementation of xeroderma pigmentosum cells by micro-injection of poly(A)+ RNA
30. Genetic transformation of mouse embryos by micro-injection of purified DNA
31. Human neonatal lymphocytes immortalized after micro-injection of Epstein-Barr virus DNA
32. G-protein α subunit Gi-α-2 mediates erythropoietin signal transduction in human erythroid precursors
33. Functional isolation and characterization of human hematopoietic stem cells
34. Glass needle-mediated micro-injection of macromolecules and transgenes into primary human blood stem/progenitor cells
35. Lipid-assisted micro-injection: Introducing material into the cytosol and membranes of small cells
36. Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults
37. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients
38. Evidence that hematopoiesis may be a stochastic process in vivo
39. Single cell assay with an automated capillary micro-injection system
40. Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin
41. Influence of cytokines on the growth kinetics and immunophenotype of daughter cells resulting from the first division of single CD34+Thy-1+lin- cells
42. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lymphomyeloid repopulating activity in non-obese diabeticscid/scid mice
43. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture
44. Engraftment in non-obese diabetic severe combined immunodeficient mice of human CD34+ cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells
45. Fate and structure of DNA micro-injected into mouse TK-L cells
46. Patterns of integration of DNA micro-injected into cultured mammalian cells: Evidence for homologous recombination between injected plasmid DNA molecules
47. Genetics of retroviral integration
48. Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences
49. Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein
50. Formation of de novo centromeres and construction of first-generation human artificial microchromosomes
51. Human gene targeting by viral vectors
52. High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors
53. Gene targeting of CFTR DNA in CF epithelial cells
54. Targeted replacement of normal and mutant CFTR sequences In human airway epithelial cells using DNA fragments
55. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide
56. Targeted gene conversion in a mammalian CD34+ enriched cell population using a chimeric RNA/DNA oligonucleotide
57. Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome type I with a chimeric oligonucleotide
58. Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor
59. Mutagenesis in mammalian cells induced by triple helix formation and transciption-coupled repair
60. Multilineage potential of adult human mesenchymal stem cells
61. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation
62. Marrow stromal cells as stem cells for non-hematopoietic tissues
63. Bone marrow as a potential source of hepatic oval cells
64. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation
65. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells
66. Identification of a neural stem cell in the adult mammalian central nervous system